Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
NASA Artemis II tracker: Crew less than 60,000 miles from moon ahead of Monday flyby - 2Everyday Seasonal Positions That Compensate Fairly in the US
- 36 U.S. States for Climbing
- 4South African radio presenter among five charged over Russia recruitment plot
- 5Kona SUV: Exploring the Future with Hyundai's Visionary Hybrid
- The Starbucks for Life game is back, along with your chance to win a 'Bearista' cold cup. Here's how to get your paws on one.
- Turning to turkey’s tryptophan to boost mood? Not so fast
- As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves
- Portugal among EU countries with the most people working close to 50 hours a week
- Defence chiefs of Thailand and Cambodia to discuss ceasefire
- 8 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN
- The Most recent Microsoft Surface Star PC: Ideal for Top of the line Planning and Gaming Needs
- Alix Earle built trust by sharing her acne woes. Now her skin care line is raising questions.
- Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
